Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation. | J Physiol | 2026 | 41762213 | PubTator, text mining | PubMed |
| Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | 41760388 | PubTator, text mining | PubMed |
| Special Issue "Cellular and Molecular Insights into Ocular Changes Associated with Systemic Disorders and Conditions". | Int J Mol Sci | 2026 | 41752160 | PubTator, text mining | PubMed |
| Lipid Regulation of Mechanosensitive Ion Channels. | Int J Mol Sci | 2026 | 41752117 | PubTator, text mining | PubMed |
| Curcumin as a Multi-Target Bioactive Molecule: Mechanistic Insights and Translational Perspectives. | Int J Mol Sci | 2026 | 41751968 | PubTator, text mining | PubMed |
| Modulation of Nociceptive Ion Channels by Protease-Activated Receptor-2 in Inflammatory Pain: Molecular Mechanisms and Therapeutic Potential. | Int J Mol Sci | 2026 | 41751907 | PubTator, text mining | PubMed |
| The Analgesic Effects of Nrf2 Activators in Chemotherapy-Induced Neuropathic Pain: Evidence from Animal Studies and Consequences for Translation into Clinical Trials. | Int J Mol Sci | 2026 | 41751884 | PubTator, text mining | PubMed |
| The Synthetic Extracellular Matrix as a Maestro of the In Vitro Stem Cell Niche: Orchestrating Fate and Function. | Biomedicines | 2026 | 41751384 | PubTator, text mining | PubMed |
| Tissue-Specific Multi-Omics Integration Demonstrates Molecular Signatures Connecting Obesity to Immune Vulnerability. | Metabolites | 2026 | 41745578 | PubTator, text mining | PubMed |
| TRPV4 Deficiency Shifts Mitochondrial Dynamics Toward a Fragmented Morphology in Primary Microglia. | Cells | 2026 | 41744784 | PubTator, text mining | PubMed |
| The Prospects of Electromagnetic Stimulation in Cartilage and Bone Tissue Engineering. | Cells | 2026 | 41744768 | PubTator, text mining | PubMed |
| Biophysical signal-driven scaffold design for stem cell-guided osteochondral regeneration. | Bioact Mater | 2026 | 41743835 | PubTator, text mining | PubMed |
| Chronic kidney disease-associated pruritus: a perspective on skin barrier damage. | Ren Fail | 2026 | 41742460 | PubTator, text mining | PubMed |
| Piezo1 as a mechanical checkpoint in T cell immunotherapy for solid tumors. | Front Pharmacol | 2026 | 41737555 | PubTator, text mining | PubMed |
| An integrative ultrastructural and transcriptomic analysis of host-pathogen interactions with human brain microvascular endothelial cells during cryptococcal infection: a preliminary study. | Front Cell Infect Microbiol | 2026 | 41736794 | PubTator, text mining | PubMed |
| Progress in the study of ion channel function, mechanisms, and mathematical modeling in Parkinson's disease. | iScience | 2026 | 41732483 | PubTator, text mining | PubMed |
| Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 41727505 | PubTator, text mining | PubMed |
| In vitro phenotypically stable cartilage regeneration with mechanically adaptable microenvironment using a hydrostatic pressure bioreactor. | Bioact Mater | 2026 | 41727271 | PubTator, text mining | PubMed |
| T Cell Receptor Co-Stimulation Through Magnetogenetic Tools: A Platform for Wireless Rewiring of Cellular Signaling. | ACS Omega | 2026 | 41726657 | PubTator, text mining | PubMed |
| From inflammatory activation to fibrotic remodeling: the central role of macrophage heterogeneity in frozen shoulder. | Front Immunol | 2026 | 41716412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=7